Who Paid My Doc
Opana
Drug Pain
NDC 63481-612-70
General payments
$1,095
Research payments
$584,531
Through program year 2024, $1,095 in general payments and $584,531 in research payments were reported against Opana (Pain).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $500 | 1 |
| 2022 | General | $500 | 1 |
| 2022 | Research | $13,200 | 2 |
| 2021 | Research | $100,028 | 16 |
| 2020 | Research | $99,765 | 20 |
| 2019 | General | $95 | 1 |
| 2019 | Research | $371,538 | 25 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
3 general · 63 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.